WALKER MEDICAL GROUP
CHURCH WALK, NEWCASTLE UPON TYNE
HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 34 | 48 | 70.8% | |
| HF 4 | 2011 | 51 | 55 | 92.7% | |
| HF 4 | 2012 | 66 | 71 | 93.0% | |
| HF 4 | 2013 | 75 | 87 | 86.2% | |
| HF004 | 2014 | 16 | 17 | 94.1% | |
| HF004 | 2015 | 18 | 20 | 90.0% | |
| HF004 | 2016 | 21 | 22 | 95.5% | |
| HF004 | 2017 | 18 | 19 | 94.7% | |
| HF004 | 2018 | 39 | 40 | 97.5% | |
| HF004 | 2019 | 44 | 44 | 100.0% | |
| HF004 | 2020 | 42 | 48 | 87.5% | |
| HF006 | 2021 | 53 | 56 | 94.6% | |
| HF006 | 2022 | 57 | 58 | 98.3% | |
| HF006 | 2023 | 68 | 72 | 94.4% |
